Almost 18,000 civilians evacuated from areas of Aleppo controlled by militantsWorld December 10, 7:41
Russian swimmers win 11 sets of medals at FINA World Swimming Championships (25 m)Sport December 10, 7:00
Shiveluch volcano in Russia’s Far East spews ash to 11 km in airWorld December 10, 5:28
Ceasefire agreements enter into force near Damascus, in Idlib province ― mediaWorld December 10, 4:18
Russian pair Tarasova/Morozov win final of ISU Grand Prix of Figure Skating in MarseillesSport December 10, 4:00
Matviyenko to visit UAE to participate in Forum of Women Speakers of ParliamentRussian Politics & Diplomacy December 10, 3:21
Doping samples of all athletes from past three Olympics should be re-analyzed ― lawmakerSport December 10, 2:01
Russia’s figure skater Medvedeva leads with world record after SP at Grand Prix finalsSport December 10, 1:28
Russian energy minister expects OPEC, non member countries to sign agreement on oil outputBusiness & Economy December 10, 0:46
“We do not have the reasons that caused the epidemic in West Africa”, that is natural hotbeds and difficult social and economic conditions, the scientist said.
“There is always a small kernel of probability a virus will infiltrate Russia but even in theory we have no foundation for the emergence of natural hotbeds, while our medical service is so strong that even if this scenario is realized, it will be soon jugulated,” said Shchelkanov.
Use of untested experimental vaccine against Ebola fever in West Africa is justified given the scale of the epidemic, he said.
“Obviously, it is justified since it is the first time we are facing such a large-scale epidemic with such a high death toll,” said Shchelkanov who returned from West Africa on Wednesday. “The end justifies the means here. It is quite a justified and reasonable decision.
“We’ll see no immediate results,” said the scientist. “Not in over the short term but quite probably over the medium term.”
“Obviously, it [use of untested Ebola vaccine] is justified since it is the first time we are facing such a large-scale epidemic in such a difficult region with such a high death toll,” said Shchelkanov who returned from West Africa on Wednesday. “The end justifies the means here. It is quite a justified and reasonable decision.”
Ebola virus death toll fell thanks to work of diagnostic centres, he added.
“Mortality rate is at a high level but it would be even higher but for the diagnostic centres. Development of the laboratory diagnostic methods dropped the death count,” said the scientist who came back from fever-stricken West Africa on Wednesday.
While doctors previously dealt only with severe cases, now even milder cases were considered, and “this, naturally, drops lethality,” he said.
Ebola fever has affected 1,975, killed 1,069 - 377 in Guinea, 365 in Liberia, 334 in Sierra Leone and three in Nigeria.